C-ring-substituted pregn4-ene-21,17-carbolactone, and pharmaceutical preparations comprising the latter

Details for Australian Patent Application No. 2009254266 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Prelle, Katja; Bohlmann, Rolf; Zorn, Ludwig; Kuhnke, Joachim; Borden, Steffen; Ring, Sven

Agent Davies Collison Cave

Pub. Number AU-A-2009254266

PCT Pub. Number WO2009/146811

Priority 10 2008 026 793.7 02.06.08 DE

Filing date 26 May 2009

Wipo publication date 10 December 2009

International Classifications

C07J 53/00 (2006.01) Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by condensation with carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61P 5/28 (2006.01) Drugs for disorders of the endocrine system

A61P 5/34 (2006.01) Drugs for disorders of the endocrine system

A61P 5/42 (2006.01) Drugs for disorders of the endocrine system

Event Publications

23 December 2010 PCT application entered the National Phase

  PCT publication WO2009/146811 Priority application(s): WO2009/146811

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009254268-Polyurethane coatings for thermally regulating and the use thereof

2009254262-Compositions for the treatment of disorders of the upper respiratory tract and influenza syndromes